These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
432 related articles for article (PubMed ID: 31574071)
41. Treatment of nonalcoholic fatty liver disease in adults and children: a closer look at the arsenal. Nobili V; Sanyal AJ J Gastroenterol; 2012 Jan; 47(1):29-36. PubMed ID: 21983927 [TBL] [Abstract][Full Text] [Related]
42. Nonalcoholic fatty liver disease in children: recent practice guidelines, where do they take us? Aggarwal A; Puri K; Thangada S; Zein N; Alkhouri N Curr Pediatr Rev; 2014; 10(2):151-61. PubMed ID: 25088269 [TBL] [Abstract][Full Text] [Related]
43. [Non-alcoholic fatty liver disease--new view]. Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346 [TBL] [Abstract][Full Text] [Related]
44. Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: The TARGET-NASH study. Barritt AS; Gitlin N; Klein S; Lok AS; Loomba R; Malahias L; Powell M; Vos MB; Weiss LM; Cusi K; Neuschwander-Tetri BA; Sanyal A Contemp Clin Trials; 2017 Oct; 61():33-38. PubMed ID: 28735109 [TBL] [Abstract][Full Text] [Related]
45. Nonalcoholic fatty liver disease in pediatric patients--a problem that is "enormous" and "growing"! Rosenthal P JPEN J Parenter Enteral Nutr; 2012 Jan; 36(1 Suppl):7S-8S. PubMed ID: 22237882 [No Abstract] [Full Text] [Related]
46. New scoring system combining the FIB-4 index and cytokeratin-18 fragments for predicting steatohepatitis and liver fibrosis in patients with nonalcoholic fatty liver disease. Tada T; Kumada T; Toyoda H; Saibara T; Ono M; Kage M Biomarkers; 2018; 23(4):328-334. PubMed ID: 29308929 [TBL] [Abstract][Full Text] [Related]
47. A Single-Center Study of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Recurrence in Recipients of Liver Transplant for Treatment of Nonalcoholic Steatohepatitis Cirrhosis. Matsuoka L; Chotai PN; Slaughter J; Campbell K; Kerr A; Hamel S; Garza C; Alexopoulos SP; Scanga A Exp Clin Transplant; 2022 Feb; 20(2):150-156. PubMed ID: 35037605 [TBL] [Abstract][Full Text] [Related]
49. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes. Cholankeril G; Wong RJ; Hu M; Perumpail RB; Yoo ER; Puri P; Younossi ZM; Harrison SA; Ahmed A Dig Dis Sci; 2017 Oct; 62(10):2915-2922. PubMed ID: 28744836 [TBL] [Abstract][Full Text] [Related]
50. Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab Emirates, 2017-2030. Alswat K; Aljumah AA; Sanai FM; Abaalkhail F; Alghamdi M; Al Hamoudi WK; Al Khathlan A; Al Quraishi H; Al Rifai A; Al Zaabi M; Babatin MA; Estes C; Hashim A; Razavi H Saudi J Gastroenterol; 2018; 24(4):211-219. PubMed ID: 29956688 [TBL] [Abstract][Full Text] [Related]
51. Two cases from the spectrum of nonalcoholic steatohepatitis. Abdelmalek M; Ludwig J; Lindor KD J Clin Gastroenterol; 1995 Mar; 20(2):127-30. PubMed ID: 7769192 [TBL] [Abstract][Full Text] [Related]
52. From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients: diagnosis and management. Lemoine M; Serfaty L; Capeau J Curr Opin Infect Dis; 2012 Feb; 25(1):10-6. PubMed ID: 22183113 [TBL] [Abstract][Full Text] [Related]